AN-DTPA Drug Patent Profile
✉ Email this page to a colleague
When do An-dtpa patents expire, and what generic alternatives are available?
An-dtpa is a drug marketed by Jubilant Draximage and is included in one NDA.
The generic ingredient in AN-DTPA is technetium tc-99m pentetate kit. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the technetium tc-99m pentetate kit profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for An-dtpa
A generic version of AN-DTPA was approved as technetium tc-99m pentetate kit by CURIUM on March 26th, 2025.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AN-DTPA?
- What are the global sales for AN-DTPA?
- What is Average Wholesale Price for AN-DTPA?
Summary for AN-DTPA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 105 |
| DailyMed Link: | AN-DTPA at DailyMed |
US Patents and Regulatory Information for AN-DTPA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jubilant Draximage | AN-DTPA | technetium tc-99m pentetate kit | INJECTABLE;INJECTION | 017714-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
